Company Performance Metrics
Respiro Diagnostics develops non-invasive breath-based diagnostic tests focused on respiratory and oncology applications. The company builds a breath-based diagnostic platform that combines a proprietary collection device with molecular laboratory analysis to capture extracellular vesicles and other lung-derived biomarkers from exhaled breath. Its
initial applications target earlier and more accurate detection of lung cancer and mesothelioma, with extension to other respiratory conditions and cancer research. Clinicians collect breath samples in minutes using the Respiro device and send them to the Respiro lab for high-resolution molecular profiling. The resulting reports are provided back to clinicians to support screening decisions, referrals, and treatment planning. Respiro Diagnostics also supports drug development and clinical research by generating rich molecular data from the lungs for use in studies and experimental therapies.
